A Study of Risk Factors for the COVID-19 Virus Infection
NCT04697927 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 389
Last updated 2026-01-09
Summary
The purpose of this study is to collect information that will help the reasearchers learn more about COVID-19 infections in cancer patients, and to find out about the effects of these infections on cancer treatment and outcomes. The research study involves asking people to complete a series of online questionnaires that include questions about their medical history, lifestyle, and risk factors related to the COVID-19 infection. The study will enroll both MSK patients and their household family members.
Conditions
- COVID-19 Infections in Cancer Patients
Interventions
- OTHER
-
Questionnaires
The epidemiologic questionnaires used in this study are a composite of validated questions from multiple sources. Many of the questions are an expansion of the MSK General Medical Health clinical questionnaire. Validated questions capturing demographics, employment, risk behaviors, family history, as well as, specific research domains including psychosocial, food security, and financial toxicity have already been utilized in other MSK minimal risk studies. The COVID-19 symptom and history tracker questions were largely drawn from the COronavirus Pandemic Epidemiology (COPE) consortium study.
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Jonine Bernstein, PhD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-30
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
NCT05390827 ·Status: RECRUITING
-
COVID-19 and Cancer Consortium Registry
NCT04354701 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Explore Biomarkers in Samples of Blood, Urine, Stools, Hair Follicles and Saliva From Patients With Cancer
NCT05574738 ·Status: RECRUITING
-
Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes
NCT00745160 ·Status: COMPLETED
-
Morehouse Total Cancer Care Protocol
NCT04804878 ·Status: RECRUITING
-
Collection of Blood From Patients With Cancer
NCT00034216 ·Status: RECRUITING
-
Community Cancer Centers Pilot Patient Survey
NCT00786656 ·Status: COMPLETED
-
Using MC1R Genotype to Impact Melanoma Risk Behavior
NCT03509467 ·Status: COMPLETED ·Phase: NA
-
Study of Hair Samples From Patients With Cancer
NCT00899691 ·Status: COMPLETED
-
A Study of Observation and Follow-up in People With Basal Cell Carcinoma
NCT05473507 ·Status: ACTIVE_NOT_RECRUITING
-
DNA Repair and Genetic Susceptibility to Lung Cancer
NCT00611598 ·Status: COMPLETED
-
Biomarkers in Patients With Head and Neck Cancer
NCT01466257 ·Status: COMPLETED
-
BRCA1 Haploinsufficiency and Gene Expression
NCT00597987 ·Status: COMPLETED
-
Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors
NCT05683353 ·Status: ACTIVE_NOT_RECRUITING
-
Virus-associated Tumour Microenvironment: Characterisation and Immunological Mechanisms of Resistance to Anti-tumour Treatments
NCT07028866 ·Status: NOT_YET_RECRUITING
-
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
NCT01919749 ·Status: COMPLETED ·Phase: NA
-
Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers
NCT01528774 ·Status: COMPLETED
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
NCT01503619 ·Status: COMPLETED
-
Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment
NCT06851975 ·Status: RECRUITING ·Phase: NA
-
Microbiome in Head and Neck Squamous Cell Carcinoma
NCT05837221 ·Status: RECRUITING
-
Interest and Impact of Skin Cancer Genetic Testing
NCT02941900 ·Status: COMPLETED
-
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
NCT04526587 ·Status: RECRUITING
-
Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
NCT01209299 ·Status: COMPLETED
-
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
NCT03977402 ·Status: RECRUITING
-
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer
NCT00898781 ·Status: TERMINATED